title: A 35-year-old immunocompromised man with cough of three weeks duration. Pneumocystis pneumonia.
authors.affiliation: Louisiana State University Health Sciences Center, Department of Internal Medicine, New Orleans, USA.
authors.forename: Jen K
authors.initials: JK
authors.lastname: Erbil
authors.forename: Caroline R
authors.initials: CR
authors.lastname: Alquist
authors.forename: David L
authors.initials: DL
authors.lastname: Smith
authors.forename: J Brent
authors.initials: JB
authors.lastname: Wallis
authors.forename: Fred A
authors.initials: FA
authors.lastname: Lopez
mesh_terms: D000328:Adult; D000900:Anti-Bacterial Agents / Q000008:administration & dosage; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage; D001992:Bronchoalveolar Lavage Fluid / Q000382:microbiology; D018791:CD4 Lymphocyte Count; D015658:HIV Infections / Q000150:complications / Q000276:immunology; D006801:Humans; D016867:Immunocompromised Host; D008297:Male; D045363:Pneumocystis carinii / Q000302:isolation & purification*; D011020:Pneumonia, Pneumocystis / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology / Q000209:etiology / Q000503:physiopathology; D011241:Prednisone / Q000008:administration & dosage*; D012307:Risk Factors; D016622:Silver Staining / Q000379:methods; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000008:administration & dosage*
chemical_list: D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D011241:Prednisone